These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8767003)

  • 1. Quantitative screening for fluconazole-amphotericin B antagonism in several Candida albicans strains by a comparative agar diffusion assay.
    Scheven M; Scheven C
    Mycoses; 1996; 39(3-4):111-4. PubMed ID: 8767003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of fluconazole-amphotericin B antagonism to Candida albicans by agar diffusion.
    Scheven M; Senf L
    Mycoses; 1994; 37(5-6):205-7. PubMed ID: 7898518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polyene-azole antagonism in liquid cultures of Candida albicans using an automated turbidometric method.
    Samaranayake YH; Samaranayake LP; Yeung KW
    Chemotherapy; 2001; 47(4):279-91. PubMed ID: 11399865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro.
    Scheven M; Schwegler F
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1779-83. PubMed ID: 7486918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.
    Ernst EJ; Klepser ME; Pfaller MA
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):205-10. PubMed ID: 9884837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-antibiotic effect and post-expositional polyene antagonism of azole antifungal agents in Candida albicans: dependence on substance lipophilia.
    Scheven M; Scheven C; Hahn K; Senf A
    Mycoses; 1995; 38(11-12):435-42. PubMed ID: 8720192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postantifungal effect and effects of low concentrations of amphotericin B and fluconazole on previously treated Candida albicans.
    Mínguez F; García MT; Lima JE; Llorente MT; Prieto J
    Scand J Infect Dis; 1996; 28(5):503-6. PubMed ID: 8953682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
    Dannaoui E; Colin S; Pichot J; Piens MA
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):228-32. PubMed ID: 9131326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
    Klepser ME; Wolfe EJ; Jones RN; Nightingale CH; Pfaller MA
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1392-5. PubMed ID: 9174207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
    Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of semisolid agar screening tests for determining fluconazole and amphotericin B susceptibilities of Candida strains by using three different media.
    Esen N; Yücesoy M; Yuluğ N
    J Chemother; 2003 Feb; 15(1):37-42. PubMed ID: 12678412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species.
    Lewis RE; Diekema DJ; Messer SA; Pfaller MA; Klepser ME
    J Antimicrob Chemother; 2002 Feb; 49(2):345-51. PubMed ID: 11815578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of a prenylated flavonoid from Dalea elegans with fluconazole against azole- resistant Candida albicans.
    Barceló S; Peralta M; Calise M; Finck S; Ortega G; Diez RA; Cabrera JL; Pérez C
    Phytomedicine; 2017 Aug; 32():24-29. PubMed ID: 28732804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.